Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Pulnovo Medical Announces First Enrollment in Singapore for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease 2024-08-09 17:09
Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo 2024-08-08 23:00
T-MAXIMUM PHARMACEUTICAL Announces Latest Clinical Advances in Allogeneic CAR-T Cell Therapy Breakthrough for Solid Tumors 2024-08-08 20:00
MALAYSIA HEALTHCARE TRAVEL COUNCIL (MHTC) CONTINUES TO ENHANCE AND ELEVATE THEIR "EXPERIENCE MALAYSIA HEALTHCARE (EMH) STORIES" SERIES WITH EPISODE 3 2024-08-08 16:10
WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers 2024-08-08 16:00
WestGene to Advance Clinical Trials Following Dual IND Approvals for World's First EB Virus-Related mRNA Therapeutic Cancer Vaccine 2024-08-08 10:59
Morinaga Nutritional Foods Vietnam Promoting Sustainable Development with Advanced Technology, Unique functional ingredient, and Green Production 2024-08-08 10:56
Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth 2024-08-08 00:00
PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells 2024-08-07 23:37
Concord Medical Regains Compliance with NYSE Minimum Price Requirement 2024-08-07 20:30
Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States 2024-08-07 20:00
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC) 2024-08-07 19:00
Sanyou Pharmaceuticals and JiAnTeBo Biotechnology Forge Strategic Partnership to Jointly Develop New Agonist Antibody Drugs 2024-08-07 18:00
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-07 10:05
GSK's Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer 2024-08-07 09:00
Senhwa Biosciences receives US FDA Study May Proceed letter for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors 2024-08-07 08:49
Datasea's Digital Technology Subsidiary Selected as Prospective Partner for Future Projects with Subsidiary of China Mobile 2024-08-06 21:30
Antimicrobial Materials Sector Surges Amid Hygiene and Health Revolution 2024-08-06 21:00
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study 2024-08-06 21:00
PHYLEX VACCINE ON TRACK TO COMBAT DEADLY NIPAH VIRUS WITH POSITIVE RESULTS OF IMMUNOGENICITY STUDY 2024-08-06 20:00
1 47 48 49 50 51 1619